Presentations

Nerbrink O. Workshop organizer; Inhalation Drug Delivery Device Technology Masterclass: A comprehensive guide to successfully developing inhalation products, Informa conference, 27-29 September 2010, London, UK.

Nerbrink O. Plenar lecture; The future therapies – Future DPI technologies Management Forum DPI conference, 29-30 June, 2010, London, UK.

Nerbrink O, Novel devices and points to consider when optimising performance, Inhalation Drug Development, 22-23 September, 2009, London, UK.

Nerbrink O, Recent Trends in Nanodrug Delivery – Innovation Technologies and Commercial Vialibility, International Conference and Exhibition on Nanotechnology and Advanced Materials, 11-14 December 2007

Nerbrink O, Formulation and inhalers:their interaction and the consequence for aerosol performance, Particle Design for Oral Dosage forms, 15-18 October 2007, Amsterdam, Netherlands.

Nerbrink O, Application of nano technology in oral inhalation device technology, PharmaMedDevice Conference, 24-26 April, 2007,New York, USA.

Nerbrink O, Keynote address: Mapping Inhaled Drug Delivery, 5th Annual Intranasal, Inhaled and Pulmonary Drug Development and Delivery Symposium, 10-11 Oct 2006, Washington DC, USA

Nerbrink O, The pulmonary delivery of powder and liquid drugs, Drug Delivery Global Summit, 20-21 Sept, 2006 London, UK

Nerbrink O, Novel technology possibilities for protein /peptide delivery, Dry Powder Inhalers conference, 29-30 June, 2006, London, UK

Nerbrink O, Inhaled protein and peptide device overview, Drug Delivery 2006, 17-19 May, San Diego, USA

Nerbrink O, In vitro aerosol characterisation technologies, Medical Plastics Seminar, 14-15 Nov, 2005, Copenhagen, Denmark

Nerbrink O, 2nd Annual Drug Delivery Systems 2005 Conference, Inhaled Insulin: a potential starter for large molecular delivery through the lungs? 6-7 Sept, 2005, London, UK

Nerbrink O, An update on Insulin administration by ADI, Aqueous droplet inhaler conference, 11-12 Oct, 2004, London, UK

Nerbrink O, Inhalation Devices, DPI, pMDI and Nebulizers: a Short up to date Overview, Pharmaceutical and Medical Packaging conference, 13-14 May 2003, Copenhagen, Denmark.

Nikander K, Berg E and Nerbrink O. Impact Of Breathing Patterns On Output Rate And Particle Size Of Nebulized Budesonide And Terbutaline During Inhalation, Drug Delivery to the Lungs XIII, 2002 (Poster)

Nerbrink O. Presentation the nebuliser potential at internal workshop on protein and peptide drug delivery, 1 day, October 1999 Södertälje

Nerbrink O. A Future for Nebuliser Therapy. Management Forum. Sept 20-21, 1999, London, England.

Pieron C A, Nerbrink O, Pagel J and Dennis J H. Development and application of a low flow casade impactor to size liquid aerosol. Environmental Science Departmental Research Conference. Jan 1999. Canada, (presented by Pieron)

Nerbrink O. Drug delivery to the Lung. The history of nebulisation; clinical perspective. Workshop: Recent advances in inhalation therapy, March 1997, Malaga, Spain.

Nerbrink O and Ekelius C. Investigation of the pulse form of two different commercial dosimeters. ISAM Sept 1997, Sendai, Japan.

Nerbrink O, Fagerström P-O, Wendel T, Eirefelt S, Källén ., Marchner H and Dahlbäck M. FIDO – a novel inhalation device for accurate dose delivery to large animals. AAAR Oct 1996, Orlando, FL, USA.

Nerbrink O and Svartengren M. TGLD2, a computer program for modelling of lung deposition. EAACI June 1994, Stockholm, Sweden. (Poster)

Nerbrink O and Svartengren M. TGLD2, a computer program for modelling of lung deposition. NOSA Nov 1994, Lund, Sweden.

Nerbrink O and Dahlbäck M. Basic nebuliser function. ISAM March 1993, Garmish-Partenkirchen, Germany.

Nerbrink O and Dahlbäck M. Basic nebuliser function. Allergy symposium, March 1993 Krakow, Poland.

Nerbrink O. Dahlbäck M and Hansson C-H. The Nebulizer function; Primary and secondary generation. European Aerosol Conference, Sept. 1992, Oxford, England.

Dahlbäck M, Eirefelt S, Nerbrink O, Prytz M and G-Wagner Z. A new aerosol delivery system to dogs. Third International Aerosol Conference, Sept, 1990, Kyoto, Japan. (presented by Wagner)

Dahlbäck, M, Eirefelt S, Karlberg I-B and Nerbrink O. Total deposition of Evans blue in aerosol exposed rats and guinea pigs. European Aerosol Conference Sept 1989, Vienna, Austria.

Berg E, Bäckström K, Dahlbäck M and Nerbrink O. Output and Particle size distribution of pulmicort suspension generated from MAD2 and PariBoy nebulizers. European Aerosol Conference, Sept 1988, Lund Sweden.

Nebrink O. Inhalation pharmacology; a new dicipline at AB Draco. NOSA Aerosolsymposium, Nov 1987, Lilleström, Norway.

Nerbrink O. Comparing measurments of non-spherical particles. NOSA Aerosolsymposium, Nov 1986, Stockholm, Sweden.

Nerbrink O. Output characteristics from three medical nebulizers. NOSA aerosol symposium, Nov 1985, Tammerfors, Finland. (Abstract)